Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dovitinib plus Docetaxel in Gastric Cancer
NCT01921673Phase 2Completed
- Sponsor
- Asan Medical Center
- Start
- Aug 2013
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dovitinib in gastric cancer (GC), sponsored by Asan Medical Center. Started Aug 2013; status: completed.
02
Drugs
dovitinib
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT01921673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01921673.